Stryker Corp (N:SYK)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 2825 Airview Blvd
KALAMAZOO MI 49002
Tel: N/A
Website: https://www.stryker.com
IR: See website
<
Key People
Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Glenn S. Boehnlein
Chief Financial Officer, Vice President
Viju S. Menon
Group President - Global Quality and Operations
J. Andrew Pierce
Group President - MedSurg and Neurotechnology
Spencer S. Stiles
Group President - Orthopaedics and Spine
M. Kathryn Fink
Chief Human Resource Officer, Vice President
William E. Berry
Chief Accounting Officer, Vice President
Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Robert S. Fletcher
Vice President, Chief Legal Officer
Business Overview
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker's geographical segments include the United States and the International.
Financial Overview
For the fiscal year ended 31 December 2023, Stryker Corp revenues increased 11% to $20.5B. Net income increased 34% to $3.17B. Revenues reflect MedSurg and Neurotechnology segment increase of 12% to $11.84B, Orthopaedics and Spine segment increase of 11% to $8.66B, United States segment increase of 10% to $6.19B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 11% to $2.62B, Other countries segment increase of 17% to $677M.
Employees: 52,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $133,758M as of Dec 31, 2023
Annual revenue (TTM): $20,498M as of Dec 31, 2023
EBITDA (TTM): $5,369M as of Dec 31, 2023
Net annual income (TTM): $3,165M as of Dec 31, 2023
Free cash flow (TTM): $1,997M as of Dec 31, 2023
Net Debt Last Fiscal Year: $9,942M as of Dec 31, 2023
Shares outstanding: 380,469,830 as of Mar 11, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.